20 results
IDSA Treatment Recommendations for Cryptococcal Meningoencephalitis - Induction, Consolidation and Maintenance Therapy

Table 2. Antifungal Treatment Recommendations
IDSA Treatment Recommendations ... and Maintenance Therapy ... Table 2. ... Meningoencephalitis #IDSA ... Treatment #management #meningitis
IDSA Treatment Recommendations for Cryptococcal Meningoencephalitis in Human Immunodeficiency Virus Infected Individuals
Induction therapy:
 • AmBd (0.7–1.0
IDSA Treatment Recommendations ... for Cryptococcal ... Meningoencephalitis #IDSA ... Treatment #management #meningitis ... #cryptococcus #
IDSA Recommendations for empirical antimicrobial therapy for purulent meningitis based on patient age and specific predisposing
IDSA Recommendations ... antimicrobial therapy ... for purulent meningitis ... condition #IDSA ... #Meningitis #Antibiotics
Recommendations for specific antimicrobial therapy in bacterial meningitis based on isolated pathogen and susceptibility testing.

#IDSA #Meningitis
antimicrobial therapy ... in bacterial meningitis ... #IDSA #Meningitis
Specific antibiotic in-hospital treatment for community-acquired bacterial meningitis

#bacterial #meningitis #management #antibiotics #therapy #treatment #table #duration #empiric
community-acquired bacterial meningitis ... #bacterial #meningitis ... #antibiotics #therapy ... #treatment #table
IDSA Treatment Recommendations for Cryptococcal Meningoencephalitis in Transplant Recipients
Induction therapy:
 • liposomal AmB (3–4 mg/kg per
IDSA Treatment Recommendations ... for Cryptococcal ... Meningoencephalitis #IDSA ... Treatment #management #meningitis ... #cryptococcus #
Important Fungal Stains
Mycology Lab:
 • Calcofluor white - Fluorochrome that binds glucans and chitin in fungal
polysaccharide capsule of Cryptococcus ... detection for cryptococcal ... meningitis; some ... mucopolysaccharide capsule of Cryptococcus ... fungus #comparison #table
Rare Invasive Yeasts - Species and Antifungal Therapy

Cryptococcus, 
Geotrichum, 
Kodamaea, 
(Pichia)ohmeri, 
Malassezia, 
Pseudozyma, 
Rhodotorula, 
Saccharomyces, 
Saprochaete
and Antifungal Therapy ... Cryptococcus ... Yeasts #Antifungal #Therapy ... #Management #Table
Initiation of ART in HIV patients with Opportunistic Infections
 • Pulmonary TB and CD4 cell count
regardless of CD4 • Cryptococcal ... Meningitis • ... Antiretroviral #Therapy
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... days) Preferred Therapy ... mucoadhesive buccal tablet ... chew, or crush tablet ... candida #mucosal #IDSA